Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practice

Abstract Background New drugs for locally advanced or metastatic breast cancer have led to clinical benefits, aside with increasing costs to healthcare systems. The current financing model for health technology assessment (HTA) privileges real-world data. As part of the ongoing HTA, this study aimed...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Filipa Alves da Costa, Fábio Cardoso Borges, Adriana Ramos, Alexandra Mayer, Claudia Brito, Catarina Ramos, Catarina Bernardo, Mariane Cossito, Cláudia Furtado, Arlindo R. Ferreira, Diogo Martins-Branco, Ana da Costa Miranda, António Lourenço
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2023-06-01
Saila:	Breast Cancer Research
Gaiak:	Palbociclib Effectiveness Safety Cancer registry
Sarrera elektronikoa:	https://doi.org/10.1186/s13058-023-01678-5
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!